Voices of Biotech
Podcast: MilliporeSigma says education vital to creating unbreakable chain for sustainability
MilliporeSigma discusses the importance of people, education, and the benefits of embracing discomfort to bolster sustainability efforts.
Tom Dalzel
July 1, 2009
2 Min Read
Asahi Kasei Medical Co., Ltd. is pleased to announce the commercial launch of Planova™ BioEX, its new generation of hollow-fiber membrane virus filters. Planova™ BioEX filters are specifically designed to meet the urgent need in downstream biopharmaceutical processing for robust virus filters that not only enhance safety, but also have higher filtration capacities and shorter processing times, even under demanding filtration conditions such as high protein concentration and high filtration pressure.
Developed using Asahi Kasei Medical’s unique technology base in cellulose hollow-fiber virus filters and polymer science, Planova™ BioEX filters incorporate a durable hydrophilic PVDF (polyvinylidene fluoride) hollow-fiber membrane, enabling them to cope with the harsh processing conditions typical of state-of-the-art biopharmaceutical manufacturing. Using Planova™ BioEX filters, it is now possible to safely and efficiently filter large volumes of high-protein concentration solutions, which are typically problematic for traditional types of virus removal filters, particularly those with flat membranes.
The key features of Planova™ BioEX filters are as follows:
Optimized for filtration under high protein concentrations.
Suited to high pressure filtration.
SIP (steam in place) compatible.
Superior validated virus filtration performance, even with small parvoviruses.
Various filter surface area sizes, making for easy scale up or scale down.
About Asahi Kasei Medical
Asahi Kasei Medical is the global market leader in virus filtration products. Cellulose hollow-fiber Planova™ virus removal filters from Asahi Kasei Medical have an unrivalled 20-year history of trusted use in the production of biotherapeutics, and Asahi Kasei TechniKrom, Inc. (a wholly owned US subsidiary of Asahi Kasei Medical) offers an innovative line-up of equipment solutions for bioprocessing including chromatography equipment, in-line buffer dilution systems, and virus filtration and integrity test skids.
By adding Planova™ BioEX to its family of advanced virus removal filters, Asahi Kasei Medical Co., Ltd. continues its long tradition of virus filter innovation and contribution to the enhancement of biotherapeutic virus safety. For further information about Planova™ BioEX filters, please contact the appropriate office (listed in the next column).
Our Offices
North & South America:
Asahi Kasei Medical America, Inc., Long Island Branch
1600 Stewart Ave., Suite 602, Westbury, NY 11590 USA
phone 1-516-620-3130, fax 1-516-620-3135
[email protected]
Europe:
N.V. Asahi Kasei Planova Europe S.A.
Rue Colonel Bourg, 122, 1140 Brussels, Belgium
phone 32-2-526-0500, fax 32-2-526-0510
[email protected]
Asia:
Asahi Kasei Medical Co., Ltd., Planova Division
1-105 Kanda Jinbocho, Chiyoda-ku, Tokyo 101-8101 Japan
phone 81-3-3296-3780, fax 81-3-3259-5725
[email protected]
You May Also Like
Upcoming Webcasts
Jun 17 - Jun 20, 2024
Jun 17 - Jun 20, 2024
Our Biopharmaceutical School is the perfect course to gain a well-rounded understanding of the Biopharmaceutical industry. Over three days, you will understand the principle steps in the biopharmaceutical lifecycle, including: raw material selection, up and downstream processes and core technology. Additionally, you will be familiarised with the latest industry trends, including Industry 4.0, and how these are likely to impact the industry’s evolution.
Through a combination of sessions led by experts from the likes of GSK and Pall Biotech, as well as group discussions with your peers, you will learn how to bring a biopharmaceutical drug to market. Each day will be chaired by a different member of the BioProcess International Academy faculty and there will also be time for networking and Q&As with the experts.
Learn More